PetMedix secured £27 million in its series B funding round.

Biotech Health services Pharma

United Kingdom

China

Japan

United States

Investments

06 September 2021

Share:

PetMedix (company)

United Kingdom

Biotech Health services Pharma

Total investments received (USD): 50m

Round value (USD): 37m

Round investors: Cambridge Innovation Capital Parkwalk Advisors Tencent Holdings Kyoritsu Holdings Digitalis Ventures

Company: PetMedix

Industry: Biotech Health services Pharma

Related deals

Epsilogen raised £30.8M in series B led by Novartis Venture Fund

Biotech Health services Manufacturing

United Kingdom

United States

Switzerland

Luxembourg

Investments 27 February 2022

Centauri Therapeutics raised £24M with Wren Capital, Novo, Animatrix Founders, Boehringer Ingelheim Venture Fund

Biotech Health services

United Kingdom

Germany

Denmark

Investments 25 February 2022

Biofidelity raised $23M in Series A+ funding. The round was led by Octopus Ventures and backed by SBI Investment

Biotech Health services

United Kingdom

Germany

Japan

Investments 31 January 2022

Brainomix closed a series B financing round at £16M co-led by Boehringer Ingelheim Venture Fund (BIVF) and Parkwalk Advisors

AI (big data) Biotech Health services Software Services

United Kingdom

Germany

China

Investments 07 December 2021

Synthace raised $35 million in Series C funding from Horizons Ventures and Sofinnova Partners

Biotech Health services Software Services

United Kingdom

Hong Kong

France

Investments 15 November 2021